Search

everythinglearnresearchcommunity

for

Search:↓

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Gonadal hormones may influence sex differences in play fighting in animals, but their effect on human spatial behavior is unclear and needs more research.

Hair follicle melanocytes die during hair regression.

New regenerative treatments for hair loss show promise but need more research for confirmation.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Finasteride changes hormone levels and certain proteins in rats, but these effects can be reversed after stopping the drug.

Prdm1 is necessary for early whisker development in mice but not for other hair, and its absence changes nerve and brain patterns related to whiskers.

Communication between blood vessel and hair follicle cells decreases with age, affecting hair growth and blood vessel formation.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Finasteride may help some male chronic pelvic pain patients, but more research needed.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Castration significantly reduces prostate size and BPH symptoms.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.